Health Condition 1: E103- Type 1 diabetes mellitus with ophthalmic complications Health Condition 2: E113- Type 2 diabetes mellitus with ophthalmic complications
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with Non Proliferative and Proliferative Diabetic Retinopathy
Exclusion criteria
Exclusion criteria: i. Patients receiving vitamin D and calcium supplements. ii. Patients taking any other medication that could change vitamin D metabolism, such as Rifampicin or Phenytoin. iii. Patients with very low vitamin D / sufficient vitamin levels iv. patients who have recieved injection antiVEGF for past 3 months v. patients who have recieved laser in retina for past 1 month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum levels of vascular endothelial growth factor and pigment epithelial derived growth factor after vitamin D supplementationTimepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| serum levels of vascular endothelial growth factor and pigment epithelial derived growth factor in various grades of diabetic retinopathyTimepoint: 12 weeks | — |
Countries
India
Contacts
AMUIO, JNMCH, AMU, Aligarh